Form 4: Outset Medical General Counsel Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4


Outset Medical's General Counsel, John L. Brottem, sold 1,572 shares of common stock to cover tax obligations related to previously earned and vested performance stock units.

Summary

  • John L. Brottem, General Counsel of Outset Medical, Inc., sold 1,572 shares of common stock on January 7, 2025.
  • The sale was executed at a price of $1.29 per share.
  • This transaction was to cover tax withholding obligations related to 2,530 performance stock units (PSUs).
  • The PSUs were originally earned on January 12, 2024, and vested on January 6, 2025.
  • The sale was not a discretionary trade but a 'sell to cover' transaction to meet tax obligations.
  • Following the transaction, Mr. Brottem beneficially owns 225,520 shares of Outset Medical stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction for tax purposes, which is neither positive nor negative for the company's overall outlook. The sentiment is neutral to slightly positive as it indicates the executive is managing their tax obligations.

Industry Context

This is a routine transaction for company insiders to manage tax obligations related to equity compensation. It is common for executives to sell shares to cover taxes when stock options or restricted stock units vest.

Comparison to Industry Standards

  • The sale of shares to cover tax obligations is a standard practice among executives in publicly traded companies.
  • Many companies use 'sell to cover' mechanisms to simplify the process for employees and executives.
  • The number of shares sold is relatively small compared to the total shares owned by the executive, suggesting this is a routine tax-related transaction rather than a significant change in the executive's investment position.

Stakeholder Impact

  • The sale of shares by an executive may have a minor impact on the stock price, but this transaction is not expected to have a significant impact on shareholders.
  • The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates

DateDescription
01/12/2024Performance stock units (PSUs) were originally earned by the reporting person.
01/06/2025Performance stock units (PSUs) vested and were released.
01/07/2025Sale of 1,572 shares of common stock to cover tax obligations.

Keywords

Outset Medical, insider trading, stock sale, tax obligations, performance stock units, PSUs, John L. Brottem, General Counsel, sell to cover

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.